NEXVOID’s 69% win probability suggests a controlled performance likely to avoid a decisive sweep, supporting the lean toward NEXVOID while acknowledging the risk of a competitive upset. The Under 2.5 projection aligns with this moderate confidence level, indicating an expectation of a shorter series rather than a prolonged, high-scoring battle.
